{"public_id":"co_2b27af0517304242ea238f2d7f947655","status":"active","merged_into_public_id":null,"resolved_public_id":"co_2b27af0517304242ea238f2d7f947655","name":"trial quality","description":"The methodological quality of a clinical trial, including aspects such as design and execution.","aliases":["methodological quality"],"types":["quality measure"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":6807054,"title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","citation_count":2044,"url":"https://sah.borca.ai/papers/6807054"}],"claims":[{"public_id":"cl_24288eb9eb49a263a8c77705b3c30547","text":"No analyzed methods study found poorer quality in industry-funded trials.","corpus_id":6807054,"url":"https://sah.borca.ai/claims/cl_24288eb9eb49a263a8c77705b3c30547"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_2b27af0517304242ea238f2d7f947655","url":"https://sah.borca.ai/concepts/co_2b27af0517304242ea238f2d7f947655"}